Therapeutic drug monitoring of imatinib in chronic myeloid leukemia: experience from 1216 patients at a centralized laboratory.
about
CYP2C8 Genotype Significantly Alters Imatinib Metabolism in Chronic Myeloid Leukaemia Patients.Impact of CYP2C8*3 polymorphism on in vitro metabolism of imatinib to N-desmethyl imatinib.Are nilotinib-associated vascular adverse events an under-estimated problem?Pharmacokinetic-Guided Dosing of New Oral Cancer Agents.A validated UPLC-MS/MS method for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma.Pharmacology and pharmacokinetics of imatinib in pediatric patients.Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia.Do polymorphisms in MDR1 and CYP3A5 genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinib therapy?
P2860
Q36229161-ACFCDBF7-7CC3-4BA0-BD9C-1F3775222224Q40751644-5307504E-07C0-4714-9A85-B46CC64E1FC1Q41530191-A51CB733-B9F0-4B10-9875-9042BE075336Q47969048-F0330F99-9278-43A5-BDE3-66DBF11A7F64Q49473156-E1EA8402-1678-4A97-A37A-374BE13305D9Q50094239-2DE830E7-A319-4BAB-A261-CE6B2AFF34BEQ54222903-6B13278D-64A3-4986-9FCF-5580F85E94A4Q55002373-2BE78EB2-9D16-4EAE-9B2B-A4122A7ADE21
P2860
Therapeutic drug monitoring of imatinib in chronic myeloid leukemia: experience from 1216 patients at a centralized laboratory.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Therapeutic drug monitoring of ...... s at a centralized laboratory.
@en
Therapeutic drug monitoring of ...... s at a centralized laboratory.
@nl
type
label
Therapeutic drug monitoring of ...... s at a centralized laboratory.
@en
Therapeutic drug monitoring of ...... s at a centralized laboratory.
@nl
prefLabel
Therapeutic drug monitoring of ...... s at a centralized laboratory.
@en
Therapeutic drug monitoring of ...... s at a centralized laboratory.
@nl
P2093
P2860
P356
P1476
Therapeutic drug monitoring of ...... ts at a centralized laboratory
@en
P2093
Basmah Ambrosino
Coralie Belanger
François-Xavier Mahon
Karine Titier
Nicholas Moore
Peter Schuld
Régis Lassalle
Stéphane Bouchet
Sylvie Poulette
P2860
P304
P356
10.1111/FCP.12007
P577
2012-10-31T00:00:00Z